AQR CAPITAL MANAGEMENT LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1167557
Greenwich, CT
Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$219,161,577
-$82,957,138 QoQ
Shares Held
728,039
-20.3% QoQ
Ownership
0.544%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#34
of 780 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,398 across 216 Biotechnology names. ALNY ranks #11 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in ALNY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $219,161,577 | 728,039 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $302,118,715 | 913,104 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $365,821,692 | 919,959 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $339,267,648 | 744,008 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $61,386,114 | 188,249 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $223,669,444 | 828,344 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $191,390,798 | 813,356 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $139,070,017 | 505,654 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $66,003,417 | 271,619 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $21,092,924 | 141,137 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $2,683,567 | 14,020 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $1,675,365 | 9,460 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,089,115 | 5,734 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,223,354 | 6,107 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $2,355,482 | 11,768 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $877,141 | 6,014 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,836,522 | 11,247 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $360,187 | 2,124 | Shares | Defined | 2022-02-14 | |
| 2021-03-31 | $270,237 | 1,914 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $5,152,920 | 39,647 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $10,451,313 | 71,781 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $14,097,257 | 95,181 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $5,030,829 | 46,218 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||